CLINICAL_TRIALS
trial_result
· 2026-01-26
Clinical Trial Update: Efficacy of Bilastine Up-dosing (40 mg ) Versus Combination of Bilastine (20 mg )With Levocitirizine (5 mg) in the Treatment of Chronic Spontaneous Urticaria [NA]
Summary
Completed clinical trial comparing high-dose bilastine (40 mg) to bilastine (20 mg) plus levocetirizine (5 mg) for chronic spontaneous urticaria.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Derma Techno Pakistan | Conditions: Chronic Spontaneous Urticaria (CSU) | NA | Status: COMPLETED